LON:ABDX

Abingdon Health Final Earnings Results & Report

Abingdon Health logo
GBX 8 -0.50 (-5.88%)
As of 03:48 AM Eastern

Abingdon Health reported Final earnings on October 13, 2026. The company reported EPS of -GBX 0.51.

Earnings Announcement Details

Quarter
Final
Report Date
Time
Before Market Opens

Abingdon Health EPS Results

Actual EPS
-GBX 0.51
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Abingdon Health Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Abingdon Health Final Earnings FAQ

Abingdon Health (LON:ABDX) reported earnings of -GBX 0.51 per share for Final. The report was announced on Tuesday, October 13, 2026.

Abingdon Health Earnings Headlines

Abingdon Health PLC (ABDX) AI Stock Analysis
A $247 tool for $7
Bill Poulos is offering his $247 Instant Scanner for $7 in the Black Friday sale. It's one payment for a full year, with no re-bills and nothing to install. The catch? He isn't trying to profit on the scanner itself. Poulos is betting that once you see it deliver the night's list, you'll want more of his work for years.tc pixel
UKAS ISO/IEC 17025 accreditation
See More Abingdon Health Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Abingdon Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Abingdon Health and other key companies, straight to your email.

About Abingdon Health

Abingdon Health (LON:ABDX) is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests. The Company offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Abingdon Health aims to support the increase in need for rapid results across many industries and locations and produces lateral flow tests in areas such as infectious disease, clinical testing including companion diagnostics, animal health and environmental testing. Faster access to results allows for rapid decision making, targeted intervention and can support better outcomes. This ability has a significant role to play in improving life across the world. To support this aim Abingdon Health has also developed AppDx®, a customisable image capturing technology and algorithm that transforms a smartphone into a self-sufficient, standalone lateral-flow reader. Founded in 2008, Abingdon Health is headquartered in York, England.

View Abingdon Health Profile